ASHPOfficial

Advocating for Impact: The New Practitioner Playbook: Legislative Edition

This podcast breaks down key legislative updates and explores what they mean for new practitioners. Listeners will gain practical insight into how these changes impact day-to-day practice across care settings, along with actionable ways to apply new policies in their own roles. The episode also highlights opportunities for advocacy and engagement, empowering early-career professionals to get involved and help shape the future of the profession.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Insights and Connections: A Real Conversation About 340B

What does the future hold for the 340B Drug Pricing Program? In this episode, ASHP Executive Vice President and CEO Sam Calabrese sits down with ASHP Chief Advocacy Officer and Vice President of Government Relations Tom Kraus to discuss what health-system pharmacy professionals are hearing on the ground, the real-world value the 340B program brings to patients and communities, and ASHP’s latest efforts to safeguard the program. Tune in for an inside look at the challenges, opportunities, and advocacy shaping the road ahead.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Clinical Conversations (CE): T-Cell-Engaging Bispecific Antibodies in Cancer: What the Non-Oncology Pharmacist Needs to Know about Acute Toxicities (CE)

T-cell-engaging bispecific antibodies represent a major therapeutic and scientific advancement in the treatment of several types of cancer. However, they carry a risk of some unique acute toxicities, such as cytokine release syndrome and neurologic toxicity. This podcast reviews this emerging drug class and strategies for recognition and management of their unique adverse events.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Educator Essentials: Innovating PGY2 Residency Training Through a Virtual Precepting Model

This episode explores the development of an innovative telehealth‑focused, virtual postgraduate year 2 ambulatory care residency program within the VA, highlighting how it expands access to specialized training, leverages a virtual precepting model, and prepares pharmacists for emerging virtual care roles. Speakers share insights and lessons learned from designing a virtual residency model, including strategies for overcoming implementation challenges and supporting resident success. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hot Topics in Pharmacy Practice: BiTE-Sized Breakthroughs: Clinical Data and Practice Approaches for New Indications for Advanced Therapies

BiTEs or bispecific T-cell engager antibodies are an emerging class of therapies with significant potential to advance cancer treatment. Pharmacists will play a key role both in the utilization of these agents but also in the mitigation and management of the unique toxicities that accompany them. This podcast provides insights into the patient care needs and novel interdisciplinary models employed to support patients receiving BiTE therapies. Listeners will gain key insights into BiTE therapies, including their role in treatment, the current pipeline, and safety considerations.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Research in Pharmacy Practice: Research that Moves Pharmacy Forward: Conversations with the 2025 ASHP Foundation Literature Awardees

Five recipients of the 2025 ASHP Foundation Literature Awards discuss their projects and approaches to pharmacy research.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Informatics Bytes: Echoes to Outcomes: Developing a System for Tracking and Responding to Electronic Health Record User Feedback

This episode discusses how an interdisciplinary clinical decision support (CDS) team utilizes user feedback through an integrated home-grown system. We'll focus on the team’s journey through responding to feedback, tracking enhancements generated by the feedback, and improvements to the process.  Listeners will learn how user-generated feedback on electronic health record alerts can be efficiently triaged and managed by an interdisciplinary CDS team, with a focus on therjourney from first using the feedback to the current state of the process.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

We're Your Pharmacist Podcast Series: Anastasiya Shor, PharmD, BCPS

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Anastasiya Shor, director of the drug information center and assistant professor at Touro College of Pharmacy. She shares what inspired her to pursue a career in pharmacy and offers insight into the vital role pharmacists play in supporting patients. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hot Topics in Pharmacy: ASHP Advantage: From Evidence to Action: Using Antivirals to Treat High-Risk Hospitalized Patients With COVID-19

COVID-19 is an ongoing public health challenge, and the disease continues to spread to patients every day. Numerous factors can influence the risk of adverse outcomes from COVID-19 including vaccination status, the number and type of medical conditions, immunosuppression, and age, along with sociodemographic factors and nonpharmaceutical interventions. For high-risk patients with non-severe COVID-19, antiviral medications can reduce progression to severe COVID-19 and can reduce the risk of hospitalization and death. Despite guideline recommended use of these medications and demonstrated effectiveness, the use of COVID-19 antiviral medications is low.

Pharmacists can play an important role in understanding the ongoing risks and burden of disease with COVID-19, identifying high-risk individuals including hospitalized patients who would benefit from treatment, evaluating recent clinical evidence supporting the use of antiviral therapies, and ensuring access to these therapies. This activity will discuss the most recent clinical evidence surrounding antivirals for COVID-19 and their role in improving patient outcomes.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Clinical Conversations: GLP Practice Insights: GLP-1 Receptor Agonist’s Role in Mental Health and Substance Use Disorders (CE)

This podcast is a brief review of emerging literature focusing on the potential use of GLP-1 receptor agonists in the treatment of mental health and substance use disorders. The episode explores how GLP-1 receptor agonists work to alter neurotransmitter systems and impact inflammation in the brain. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.